- Home
- SXTC vs MRCC Comparison
SXTC vs MRCC Comparison
Compare SXTC & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTC | MRCC |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 135.8M |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | SXTC | MRCC |
|---|---|---|
| Price | $2.15 | $4.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 55.5K | ★ 155.0K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | ★ 15.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $4.11 |
| 52 Week High | $6.98 | $7.99 |
Technical Indicators
Market Signals| Indicator | SXTC | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 35.89 |
| Support Level | $1.92 | N/A |
| Resistance Level | $2.37 | $6.91 |
| Average True Range (ATR) | 0.18 | 0.32 |
| MACD | -0.06 | -0.10 |
| Stochastic Oscillator | 35.57 | 34.44 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.